Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Non-Current Assets (2017 - 2026)

Inspire Medical Systems' Non-Current Assets history spans 10 years, with the latest figure at $344.6 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 116.53% to $344.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 66.53% increase, with the full-year FY2025 number at $323.7 million, up 82.27% from a year prior.
  • Non-Current Assets hit $344.6 million in Q1 2026 for Inspire Medical Systems, up from $323.7 million in the prior quarter.
  • Over the last five years, Non-Current Assets for INSP hit a ceiling of $344.6 million in Q1 2026 and a floor of $27.2 million in Q1 2022.
  • Historically, Non-Current Assets has averaged $133.9 million across 5 years, with a median of $113.6 million in 2024.
  • Biggest five-year swings in Non-Current Assets: surged 205.67% in 2024 and later grew 3.53% in 2025.
  • Tracing INSP's Non-Current Assets over 5 years: stood at $34.8 million in 2022, then soared by 138.41% to $83.1 million in 2023, then soared by 113.76% to $177.6 million in 2024, then skyrocketed by 82.27% to $323.7 million in 2025, then grew by 6.45% to $344.6 million in 2026.
  • Business Quant data shows Non-Current Assets for INSP at $344.6 million in Q1 2026, $323.7 million in Q4 2025, and $221.2 million in Q3 2025.